SMTL ID : 5fbo.1

BTK-inhibitor co-structure

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

monomer

Ligands

1 x 5WH: 4-[8-azanyl-3-[(3~{R},6~{S})-1-cyclopropylcarbonyl-6-methyl-piperidin-3-yl]imidazo[1,5-a]pyrazin-1-yl]-3-fluoranyl-~{N}-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)

5WH.1: 20 residues within 4Å: Chain A: L.20, G.23, V.28, A.40, K.42, E.57, A.58, M.61, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, L.140, S.150, D.151, L.154 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.28, A:K.42, A:T.86, A:N.96, A:L.140, A:L.154 Hydrogen bonds: A:E.87, A:M.89, A:C.93, A:D.151, A:D.151 pi-Cation interactions: A:K.42

1 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)

5WE.2: 8 residues within 4Å: Chain A: S.6, W.7, I.9, W.33, Y.37, V.39, S.65, Y.73 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.9, A:W.33, A:W.33, A:W.33, A:Y.37, A:V.39, A:Y.73, A:Y.73, A:Y.73 Hydrogen bonds: A:Y.37, A:S.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis. ACS Med Chem Lett (2016)

Release Date

2016-03-23

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence